Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
Okada S, Morimoto T, Ogawa H, Sakuma M, Soejima H, Nakayama M, Jinnouchi H, Waki M, Akai Y, Ishii H, Saito Y; Investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial. Okada S, et al. Among authors: sakuma m. PLoS One. 2016 Jan 25;11(1):e0147635. doi: 10.1371/journal.pone.0147635. eCollection 2016. PLoS One. 2016. PMID: 26808136 Free PMC article. Clinical Trial.
Incidence of adverse drug events and medication errors in Japan: the JADE study.
Morimoto T, Sakuma M, Matsui K, Kuramoto N, Toshiro J, Murakami J, Fukui T, Saito M, Hiraide A, Bates DW. Morimoto T, et al. Among authors: sakuma m. J Gen Intern Med. 2011 Feb;26(2):148-53. doi: 10.1007/s11606-010-1518-3. Epub 2010 Sep 25. J Gen Intern Med. 2011. PMID: 20872082 Free PMC article. Clinical Trial.
Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
Okada S, Morimoto T, Ogawa H, Kanauchi M, Nakayama M, Uemura S, Doi N, Jinnouchi H, Waki M, Soejima H, Sakuma M, Saito Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes Trial Investigators. Okada S, et al. Among authors: sakuma m. Diabetes Care. 2011 Jun;34(6):1277-83. doi: 10.2337/dc10-2451. Epub 2011 Apr 22. Diabetes Care. 2011. PMID: 21515838 Free PMC article. Clinical Trial.
Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
Soejima H, Ogawa H, Morimoto T, Nakayama M, Okada S, Uemura S, Kanauchi M, Doi N, Sakuma M, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators. Soejima H, et al. Among authors: sakuma m. Circ J. 2012;76(6):1526-32. doi: 10.1253/circj.cj-11-1033. Epub 2012 Mar 23. Circ J. 2012. PMID: 22447019 Free article. Clinical Trial.
782 results